Adeno-associated virus-1 illustration; the use of AAVs resurrected the gene therapy field, but companies are now testing the limits of a 20-year-old technology (File photo, Shutterstock)
After 3 deaths rock the field, gene therapy researchers contemplate AAV's future
Nicole Paulk was scrolling through her phone in bed early one morning in June when an email from a colleague jolted her awake. It was …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
